The Company’s proprietary technology is based on Dr. Paul B. Savage’s research and invention at Brigham Young University (BYU).
What sets our Ceragenins apart? These synthetic molecules are designed to mimic endogenous host defense peptides – nature’s own way of combating pathogens. They replicate the multifaceted activities of natural antimicrobial peptides, but with enhanced stability and manufacturability. Unlike peptides, Ceragenins resist proteolytic degradation and can be produced on a large scale, making them a practical solution for widespread use.